Related Experiment Video
Updated: Jun 7, 2026
08:31
Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
A genetically synthetic protein-based cationic polymer for siRNA delivery
Ying Liu1, Zhilong Jia, Liwen Li
1The College of Life Sciences, Northwest University, Xi'an, Shaanxi 710069, China.
Medical Hypotheses
|November 3, 2010
Summary
Researchers developed a novel elastin-like polypeptide (ELP) polymer for delivering small interfering RNA (siRNA). This protein-based polymer offers a promising, less cytotoxic alternative for gene therapy applications.
Area of Science:
- Biotechnology
- Polymer Science
- Gene Therapy
Background:
- RNA interference (RNAi) technology utilizes small interfering RNA (siRNA) for sequence-specific gene silencing.
- Current siRNA delivery systems, including cationic polymers and liposomes, face challenges due to severe cytotoxicity.
- There is a significant need for novel, safe, and effective polymeric vectors for siRNA delivery in therapeutic applications.
Purpose of the Study:
- To introduce a genetically synthesized, protein-based polymer as a potential carrier for siRNA delivery.
- To explore the potential of elastin-like polypeptides (ELPs) as a less cytotoxic alternative to existing cationic agents.
- To investigate the feasibility of modifying ELPs for enhanced siRNA condensation and delivery.
Main Methods:
- Genetically synthesizing elastin-like polypeptides (ELPs) based on the human tropoelastin sequence (Val-Pro-Gly-Xaa-Gly).
- Modifying the 'guest residue' (Xaa) in the ELP sequence to incorporate cationic amino acids like Lysine (Lys) or Arginine (Arg).
- Evaluating the potential of these modified ELPs as cationic polymers for siRNA condensation and delivery.
Main Results:
- Elastin-like polypeptides (ELPs) were successfully synthesized as a protein-based polymer platform.
- Alternating the guest residue to Lys or Arg creates a potent cationic polymer.
- These modified ELPs show promise as effective and potentially less cytotoxic siRNA delivery carriers.
Conclusions:
- Genetically synthesized elastin-like polypeptides (ELPs) represent a novel class of cationic polymers for siRNA delivery.
- Modified ELPs offer a promising avenue for developing safer and more effective gene therapy vectors.
- Further research and development could lead to the clinical application of ELP-based siRNA delivery systems.
Related Concept Videos
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
02:30Small interfering RNAs (siRNA)
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...